Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer

Cynthia X. Ma, Suresh Nair, Sachdev Thomas, Sumithra J. Mandrekar, Daniel A. Nikcevich, Kendrith M. Rowland, Tom R. Fitch, Harold E. Windschitl, Shauna L. Hillman, Steven E. Schild, James R. Jett, Coleman Obasaju, Alex A. Adjei

Research output: Contribution to journal › Article › peer-review

65 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences